Yun Y. Mah
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Intranasal DC-targeting vaccine booster elicits durable and cross-clade protective immunity against sarbecoviruses in mice.
Journal: The Journal of clinical investigation
Published: January 15, 2026
Cross-clade vaccination to overcome sarbecovirus or merbecovirus neutralization gaps.
Journal: Cell reports
Published: July 06, 2025
Inflammasome-Driven Fatal Acute-on-Chronic Liver Failure Triggered by Mild COVID-19.
Journal: Viruses
Published: September 02, 2024
Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccines and breakthrough infected individuals.
Journal: Scientific reports
Published: September 25, 2023
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.
Journal: Scientific reports
Published: May 12, 2023
SARS-CoV-2 Omicron variant emerged under immune selection.
Journal: Nature microbiology
Published: June 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026